Tokyo, June 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061750) titled 'Impact of minimally invasive surgery in patients with resectable pancreatic ductal adenocarcinoma following neoadjuvant chemotherapy: A multicenter retrospective cohort study' on May 31.
Study Type:
Observational
Primary Sponsor:
Institute - Okayama University Hospital
Condition:
Condition - Patients who underwent surgery for resectable pancreatic ductal adenocarcinoma following neoadjuvant chemotherapy
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - This multicenter study aimed to investigate overall outcomes of pancreatectomy, inclusing minimally invasive and open surgery, in patients with resectable pancreatic ductal adenocarcinoma following neoadjuvant chemotherapy
Basic objectives2 - Safety,Efficacy
Eligibility:
Age-lower limit - 18
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Patients who underwent pancreatectomy for resectable pancreatic ductal adenocarcinoma following neoadjuvant chemotherapy
at two high-volume centers, Fujita Health University Hospital and Okayama University Hospital, between 2008 and 2026.
Key exclusion criteria - None.
Target Size - 200
Recruitment Status:
Recruitment status - Open public recruiting
Date of protocol fixation - 2025 Year 12 Month 12 Day
Date of IRB - 2025 Year 12 Month 12 Day
Anticipated trial start date - 2026 Year 05 Month 31 Day
Last follow-up date - 2027 Year 12 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000070665
Disclaimer: Curated by HT Syndication.
